State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences

QR Code

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences

BACKGROUND Northeastern states of the United States have shown more progress in reducing colorectal cancer (CRC) incidence and mortality rates than Southern states, and this has resulted in considerable disparities. This study quantified how the disparities in CRC rates between Louisiana (a Southern...

Full description

Bibliographic Details
Main Authors:	Lansdorp_Vogelaar, Iris, Goede, S., Ma, J., Xiau-Cheng, W., Pawlish, K., Van Ballegooijen, M., Jemal, A.
Format:	Journal Article
Published:	John Wiley & Sons, Inc. 2015
Online Access:	http://hdl.handle.net/20.500.11937/49829

Similar Items

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)

Utilization of surveillance after Polypectomy in the Medicare population - A cohort study
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bo7kudcc2rnlvh6o1ce6hogokg